Immunomodulation of HIV-1 Infected Individuals With PEG-Interleukin-2
NCT00002017
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
OTHER
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
Interleukin-2, Polyethylene Glycolated
Sponsor
Rockefeller University